Get the tools used by (smart)2 investors.
SP500 -5.8%DOW -5.4%FTSE 100 -4.9%NIKKEI -2.6%OIL -6.0%GOLD -2.3%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Total Debt / EBITDA for Merck & Company Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

MRK: Merck & Company Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, incl...

- USD
Price
– USD
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Merck & Company Inc's Total Debt / EBITDA:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.5x1.5x2.5x
Performance Summary
  • Merck's latest twelve months total debt / ebitda is 1.3x
  • Merck's total debt / ebitda for fiscal years ending December 2020 to 2024 averaged 1.8x.
  • Merck's operated at median total debt / ebitda of 1.8x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Merck's total debt / ebitda peaked in December 2020 at 2.4x.
  • Merck's total debt / ebitda hit its 5-year low in December 2024 of 1.3x.
  • Merck's total debt / ebitda decreased in 2021 (2.0x, -16.7%), 2022 (1.3x, -34.9%), and 2024 (1.3x, -28.3%) and increased in 2020 (2.4x, +23.0%) and 2023 (1.8x, +39.2%).

How does Merck&Co's Total Debt / EBITDA benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Merck & Company Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Merck&Co Total Debt / EBITDA Benchmarks
NameTickerTotal Debt / EBITDA
HealthcareSECTOR:HLTH.US-0.1x
Johnson & JohnsonNYSE:JNJ1.3x
Merck & Company IncNYSE:MRK1.3x
Novartis AG ADRNYSE:NVS1.5x
AstraZeneca PLCOTCPK:AZNC.F1.7x
Zoetis IncNYSE:ZTS1.7x
Eli Lilly and CompanyNYSE:LLY1.8x
Innoviva IncNASDAQGS:INVA2.5x
Bristol-Myers Squibb CompanyNYSE:BMY2.6x
Pfizer IncNYSE:PFE2.8x
Phibro Animal Health CorporationNASDAQGM:PAHC5.3x
Cumberland Pharmaceuticals IncNASDAQGS:CPIX50.4x

Metric Usage: Total Debt / EBITDA

Hide this widget
total_debt_to_ebitda
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Total Debt / EBITDA in the risk category include:

  • Realized Volatility (60d Annualized) - Realized volatility (also known as rolling volatility) over the last 60 days.
  • Beta (5 Year) - A ratio that measures the risk or volatility of a company's share price in comparison to the market as a whole. A beta of 1.0 means that the company rises and falls in direct relationship to the movement of the benchmark index. A beta that is less than 1 indicates a stock that is less volatile than the overall market and a beta greater than 1 indicates that the stock is more volatile.
  • Debt / Tangible Equity - A ratio that measures the level of the debt relative to the book value of tangible common equity.
  • Cash And ST Investments / Total Assets - A ratio that measures a company's cash and short-term investments as a percentage of total assets.
View Full List

Search for metric or datapoint

Total Debt / EBITDA

A ratio that is calculated as Total Debt (including Capital Leases) divided by EBITDA.

Definition of Total Debt / EBITDA

Hide this widget

Total Debt / EBITDA ratio measures leverage in terms of total debt while using EBITDA as a proxy for cash flow.

Short Term Borrowings
(+) Current Portion of Long Term Debt
(+) Current Portion of Lease Liabilities
(+) Long Term Debt
(+) Long Term Lease Liabilities
(=) Total Debt

EBITDA is Earnings before Interest, Taxes, Depreciation & Amortization
Click the link below to download a spreadsheet with an example Total Debt / EBITDA calculation for Merck & Company Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-14.2x-6.2x1.8x16.3x0200400600800

The chart above depicts the distribution of total debt / ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,140 companies were considered in this analysis, and 2,055 had meaningful values. The average total debt / ebitda of companies in the sector is 0.5x with a standard deviation of 3.2x.

Merck & Company Inc's Total Debt / EBITDA of 1.3x ranks in the 74.8% percentile for the sector. The following table provides additional summary stats:

Total Debt / EBITDA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,141
Included Constituents2,055
Min-14.7x
Max16.0x
Median0.0x
Mean0.5x
Standard Deviation3.2x

You can find companies with similar total debt / ebitda using this stock screener.

All rights reserved. Terms Of Use